Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2025-12-25 @ 11:08 PM
Study NCT ID:
NCT00520767
Status:
COMPLETED
Last Update Posted:
2023-12-22
First Post:
2007-08-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-09
Start Date Type:
None
Primary Completion Date:
2010-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-06
Completion Date Type:
ACTUAL
First Submit Date:
2007-08-24
First Submit QC Date:
None
Study First Post Date:
2007-08-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-03-18
Results First Submit QC Date:
None
Results First Post Date:
2015-03-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-20
Last Update Post Date:
2023-12-22
Last Update Post Date Type:
ACTUAL